Cáncer de vesícula biliar, una visión actual
DOI:
https://doi.org/10.30944/20117582.891Palabras clave:
cáncer, vesícula biliar, diagnóstico, cálculos, pólipos, factores de riesgo, tratamiento, litiasisResumen
Introducción. El diagnóstico de cáncer de vesícula biliar se realiza generalmente de forma incidental durante el estudio de las piezas quirúrgicas o cuando la enfermedad está avanzada y se expresa por su diseminación. Muy pocas veces se diagnostica de forma preoperatoria. Corresponde a la neoplasia más común de las vías biliares y su incidencia varía de acuerdo a la región geográfica. La región andina en Latinoamérica presenta una de las mayores incidencias a nivel mundial.
Métodos. Se realizó una revisión narrativa de la literatura, para presentar una información actualizada en lo referente a los factores de riesgo (incluyendo las alteraciones genéticas y moleculares), al diagnóstico y al tratamiento de esta patología. Basados en los datos actuales, presentamos algunas recomendaciones dirigidas al diagnóstico temprano, que permita un manejo más adecuado de nuestros pacientes.
Resultados. Se han implicado nuevos factores de riesgo relacionados con la etiología del cáncer de vesícula biliar, como la obesidad, factores genéticos y moleculares. A pesar de la disponibilidad de los métodos diagnósticos imagenológicos, no ha ocurrido una importante variación porcentual en cuanto al estadio al momento del diagnóstico.
Conclusiones. El manejo quirúrgico del cáncer de vesícula biliar está indicado en los estadios más tempranos de la enfermedad y es importante evaluar las opciones terapéuticas en pacientes con enfermedad avanzada. Se considera de suma importancia el estudio anatomopatológico de la pieza quirúrgica y la revisión del informe por parte del cirujano
Descargas
Referencias bibliográficas
American Joint Committee on Cancer. AJCC cancer staging manual. 8th edition. New York: Springer International Publishing; 2017.
Hickman L, Contreras C. Gallbladder Cancer: Diagnosis, surgical management, and adjuvant therapies. Surg Clin North Am. 2019;99:337-55. https://doi.org/10.1016/j.suc.2018.12.008
Shukla SK, Singh G, Shahi KS, Bhuvan, Pant P. Staging, Treatment, and future approaches of gallbladder carcinoma. J Gastrointest Cancer. 2018;49:9-15. https://doi.org/10.1007/s12029-017-0036-5
Vilatobá M. Cáncer de vesícula y vías biliares. Rev Gastroenterol Mex. 2010;75(Supl.1):199-201.
Sandrasegaran K, Menias CO. Imaging and screening of cancer of the gallbladder and bile ducts. Radiol Clin North Am. 2017;55:1211-22. https://doi.org/10.1016/j.rcl.2017.06.005
Redondo K, Rivero S, Ruiz K, Díaz J, Lozano D, Luna L. Carcinoma adenoescamoso de la vesícula biliar, una rara variedad histológica. Rev. Colomb Cirugía. 2015;31:246-52.
De Aretxabala X, Roa I, Mora J, Pincheira O, Burgos L, Silva J, y cols. Cáncer de la vesícula biliar: manejo de pacientes con invasión de la túnica muscular. Rev Med Chile. 2004;132:183-8 https://doi.org/10.4067/S0034-98872004000200007.
International agency for research on cancer. Gallbladder cancer. World health organization. (08-11-2020) Disponible en: https://gco.iarc.fr/today/data/factsheets/cancers/12-Gallbladder-fact-sheet.pdf
Ferlay J, Ervik M, Lam F. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer 2018. (08-11-2020) Disponible en: https://gco.iarc.fr/today/home
Schmidt MA, Marcano-Bonilla L, Roberts LR. Gallbladder cancer: epidemiology and genetic risk associations. Chin Clin Oncol. 2019;8:31. https://doi.org/10.21037/cco.2019.08.13
Salazar M, Ituarte C, Abriata MG, Santoro F, Arroyo G. Gallbladder cancer in South America: epidemiology and prevention. Chin Clin Oncol. 2019;8:32. https://doi.org/10.21037/cco.2019.07.12
Vargas J, Ramos J. Aspectos actuales de la epidemiología, patogenia y tratamiento del adenocarcinoma de vesícula biliar: revisión de la literatura. Rev Medica Sanitas. 2016;19:208-23.
Prieto RG. Cáncer de vesícula biliar en una cohorte de pacientes sometidos a colecistectomía laparoscópica. Medicina. 2018;40:399-407.
Jaramillo P, Hoyos SI. Carcinoma de vesícula biliar en el Hospital Pablo Tobón Uribe de Medellín. Rev. Colomb. Cir. 2009;24:250-7.
Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019;5:93- 102. https://doi.org/10.5114/ceh.2019.85166
Stinton L, Shaffer E. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut and liver. 6;2:172-87. https://doi.org/10.5009/gnl.2012.6.2.172
Wernberg JA, Lucarelli DD. Gallbladder cancer. Surg Clin North Am. 2014;94:343-60. https://doi.org/10.1016/j.suc.2014.01.009
Diehl AK. Gallstone size and the risk of gallbladder cancer. JAMA. 1983;250:2323-6. https://doi.org/10.1001/jama.1983.03340170049027
Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591-1602. https://doi.org/10.1002/ijc.21683
Li ZM, Wu ZX, Han B, Mao YQ, Chen HL, Han SF. et al. The association between BMI and gallbladder cancer risk: a meta-analysis. Oncotarget. 2016;7:43669-79. https://doi.org/10.18632/oncotarget.9664
Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K; International Agency for Research on Cancer Handbook Working Group. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794-8. https://doi.org/10.1056/NEJMsr1606602
Torre LA, Siegel RL, Islami F, Bray F, Jemal A. Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers. Clin Gastroenterol Hepatol. 2018;16:427-37. https://doi.org/10.1016/j.cgh.2017.08.017
Vila M, Lladó L, Ramos E. Management and treatment of gallbladder polyps. Med Clin (Barc). 2018;150:487-91. https://doi.org/10.1016/j.medcli.2017.12.003
Myers RP, Shaffer EA, Beck PL. Gallbladder polyps: epidemiology, natural history and management. Can J Gastroenterol. 2002;16:187-94. https://doi.org/10.1155/2002/787598
Kwon W, Jang JY, Lee SE, Hwang DW, Kim SW. Clinicopathologic features of polypoid lesions of the gallbladder and risk factors of gallbladder cancer. J Korean Med Sci. 2009;24:481-487. https://doi.org/10.3346/jkms.2009.24.3.481
Bhatt NR, Gillis A, Smoothey CO, Awan FN, Ridgway PF. Evidence based management of polyps of the gall bladder: A systematic review of the risk factors of malignancy. Surgeon. 2016;14:278-86. https://doi.org/10.1016/j.surge.2015.12.001
Baca JE, Magaña J. Vesícula biliar “en porcelana”. Acta méd. Grupo Ángeles. 2018;16:255-7. http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1870-72032018000300255&lng=es.
Polk HC Jr. Carcinoma and the calcified gall bladder. Gastroenterology. 1966;50:582-5. https://doi.org/10.1016/S0016-5085(66)80037-9
Schnelldorfer T. Porcelain gallbladder: a benign process or concern for malignancy?. J Gastrointest Surg. 2013;17:1161-1168. https://doi.org/10.1007/s11605-013-2170-0
Ertel AE, Bentrem D, Abbott DE. Gall bladder cancer. Cancer Treat Res. 2016;168:101-20. https://doi.org/10.1007/978-3-319-34244-3_6
Khan ZS, Livingston EH, Huerta S. Reassessing the need for prophylactic surgery in patients with porcelain gallbladder: case series and systematic review of the literature. Arch Surg. 2011;146:1143-7. https://doi.org/10.1001/archsurg.2011.257
DesJardins H, Duy L, Scheirey C, Schnelldorfer T. Porcelain gallbladder: is observation a safe option in select populations? J Am Coll Surg. 2018;226:1064-9. https://doi.org/10.1016/j.jamcollsurg.2017.11.026
Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013;145:521-36. https://doi.org/10.1053/j.gastro.2013.06.052
Choi YS, Do JH, Seo SW, Lee SE, Oh HC, Min YJ, et al. Prevalence and riskfactors of gallbladder polypoid lesions in a healthy population. Yonsei Med J. 2016;57:1370-5. https://doi.org/10.3349/ymj.2016.57.6.1370
Said K, Glaumann H, Bergquist A. Gallbladder disease in patients with primary sclerosing cholangitis. J Hepatol. 2008;48:598-605. https://doi.org/10.1016/j.jhep.2007.11.019
Nagaraja V, Eslick GD. Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer. Aliment Pharmacol Ther. 2014;39:745-50. https://doi.org/10.1111/apt.12655
Mehrotra B. Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis UpToDate;- Nov18,2019. Fecha de consulta: ¿? Disponible en: ¿?
Kamisawa T, Kuruma S, Tabata T, Chiba K, Iwasaki S, Koizumi S, et al. Pancreaticobiliary maljunction and biliary cancer. J Gastroenterol. 2015;50:273-9. https://doi.org/10.1007/s00535-014-1015-2
Muraki T, Pehlivanoglu B, Memis B, Reid MD, Uehara T, Basturk O, et al. Pancreatobiliary maljunction-associated gallbladder cancer is as common in the west, shows distinct clinicopathologic characteristics and offers an invaluable model for anatomy-induced reflux-associated physio-chemical carcinogenesis. Ann Surg. 2020;269:268-35. https://doi.org/10.1097/SLA.0000000000004482
Liu B, Beral V, Balkwill A, Green J, Sweetland S, Reeves G. et al. Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study. BMJ. 2008;337:a386. https://doi.org/10.1136/bmj.a386
Sharma A, Sharma KL, Gupta A, Yadav A, Kumar aA. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol. 2017;23:3978-98. https://doi.org/10.3748/wjg.v23.i22.3978
Wistuba II, Tang M, Maitra A, Alvarez H, Troncoso P, Pimentel F, Gazdar AF. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Cancer Res. 2001;61:3795-3800.
Wistuba II, Maitra A, Carrasco R, Tang M, Troncoso P, Minna JD, et al. High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma. Br J Cancer. 2002;87:432-40. https://doi.org/10.1038/sj.bjc.6600490
Goeppert, B., Roessler, S., Renner, M. Loeffler M, Singer S, Rausch M. et al. Low frequency of mismatch repair deficiency in gallbladder cancer. Diagn Pathol. 2019;14:36. https://doi.org/10.1186/s13000-019-0813-5
Goldin RD, Roa JC. Gallbladder cancer: a morphological and molecular update. Histopathology. 2009;55:218-29. https://doi.org/10.1111/j.1365-2559.2008.03192.x
Moy AP, Shahid M, Ferrone CR, Darrell R, Borger, Andrew Z. et al. Microsatellite instability in gallbladder carcinoma. Virchows Arch. 2015;466:393-402. https://doi.org/10.1007/s00428-015-1720-0
Letelier P, Brebi P, Tapia O, Roa JC. DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer. Clin Epigenetics. 2012;4:11. https://doi.org/10.1186/1868-7083-4-11
Roa JC, Anabalón L, Roa I, Melo A, Araya JC, Tapia O. et al. Promoter methylation profile in gallbladder cancer. J Gastroenterol. 2006;41:269-275. https://doi.org/10.1007/s00535-005-1752-3
Ramachandran A, Srivastava DN, Madhusudhan KS. Gallbladder cancer revisited: the evolving role of a radiologist. Br J Radiol. 2021;94:2020-26. https://doi.org/10.1259/bjr.20200726
Renshaw AA, Gould EW. Submitting the entire gallbladder in cases of dysplasia is not justified. Am J Clin Pathol. 2012;138:374-6. https://doi.org/10.1309/AJCPB0ZTXXIF6MOF
Adsay V, Saka B, Basturk O, Roa JC. Criteria for pathologic sampling of gallbladder specimens. Am J Clin Pathol. 2013;140:278-80. https://doi.org/10.1309/AJCPUJPGQIZ6DC6A
Aloia TA, Járufe N, Javle M, Maithel S, Roa J, Adsay V, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17:681-90. https://doi.org/10.1111/hpb.12444
Amin MB, Edge SB, Greene FL, Byrd D.R., Brookland R.K., Washington M.K., et al, eds. AJCC Cancer Staging Manual, Eighth Edition. New York: Springer; 2017 https://www.springer.com/gp/book/9783319406176
Riechelmann R, Coutinho AK, Weschenfelder RF, Andrade G, Fernandes G, Gifoni M, et al. Guideline for the management of bile duct cancers by the Brazilian gastrointestinal tumor group. Arq Gastroenterol. 2016;53:5-9. https://doi.org/10.1590/S0004-28032016000100003
Babu BI, Dennison AR, Garcea G. Management and diagnosis of gallbladder polyps: a systematic review. Langenbeck’s Archives of Surgery. 2015;400:455-62. https://doi.org/10.1007/s00423-015-1302-2
McCain RS, Diamond A, Jones C, Coleman H. Current practices and future prospects for the management of gallbladder polyps: A topical review. World J Gastroenterol. 2018;24:2844-52. https://doi.org/10.3748/wjg.v24.i26.2844
Kim SY, Cho JH, Kim EJ, Chung DH, Kim KK, Park YH, et al. The efficacy of real-time colour Doppler flow imaging on endoscopic ultrasonography for differential diagnosis between neoplastic and non-neoplastic gallbladder polyps. Eur Radiol. 2018;28:1994-2002. https://doi.org/10.1007/s00330-017-5175-3
You DD, Lee HG, Paik KY, Heo JS, Choi SH, Choi DW. What is an adequate extent of resection for T1 gallbladder cancers? Ann Surg. 2008;247:835-8. https://doi.org/10.1097/SLA.0b013e3181675842
De Aretxabala X, Roa I, Hepp J, Maluenda F, Mordojovich G, Leon J, et al. Early gallbladder cancer: is further treatment necessary. J Surg Oncol. 2009;100:589-93. https://doi.org/10.1002/jso.21389
Castillo J, Csendes A, Díaz JC, Sauré A, Guajardo M, Lembach H. Cáncer temprano de la vesícula biliar. Tratamiento y sobrevida a largo plazo. Rev Chil Cir. 2014;66:417-22. https://doi.org/10.4067/S0718-40262014000500004
Kim HS, Park JW, Kim H, Han Y, Kwon W, Kim SW, et al. Optimal surgical treatment in patients with T1b gallbladder cancer: An international multicenter study. J Hepatobiliary Pancreat Sci. 2018;25:533-43. https://doi.org/10.1002/jhbp.593
Sternby-Eilard M, Lundgren L, Cahlin C, Strandell A, Svanberg T, Sandström P. Surgical treatment for gallbladder cancer - a systematic literature review. Scand J Gastroenterol. 2017;52:505-14. https://doi.org/10.1080/00365521.2017.1284895
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. Versión 2.2021. (08-04-2021) Disponible en: https://pubmed.ncbi.nlm.nih.gov/34030131/
Vega EA, Sanhueza M, Viñuela E. Minimally invasive surgery for gallbladder cancer. Surg Oncol Clin N Am. 2019;28:243-53. https://doi.org/10.1016/j.soc.2018.11.001
Isambert M, Chiche L. Segmental hepatic resection (segments IVb-V) with lymph node dissection for gallbladder cancer. J Visc Surg. 2010;147:e31-5. https://doi.org/10.1016/j.jviscsurg.2010.02.005
Kishi Y, Nara S, Esaki M, Hiraoka N, Shimada K. Extent of lymph node dissection in patients with gallbladder cancer. Br J Surg. 2018;105:1658-64. https://doi.org/10.1002/bjs.10913
Tsilimigras DI, Hyer JM, Paredes AZ, Moris D, Beal EW, Merath K, et al. The optimal number of lymph nodes to evaluate among patients undergoing surgery for gallbladder cancer: Correlating the number of nodes removed with survival in 6531 patients. J Surg Oncol. 2019;119:1099-1107. https://doi.org/10.1002/jso.25450
Fuks D, Regimbeau JM, Pessaux P, Bachellier P, Raventos A, Mantion G, et al. Is port-site resection necessary in the surgical management of gallbladder cancer? J Visc Surg. 2013;150:277-84. https://doi.org/10.1016/j.jviscsurg.2013.03.006
Vega EA, De Aretxabala X, Qiao W, Newhook TE, Okuno M, Castillo F, et al. Comparison of oncological outcomes after open and laparoscopic re-resection of incidental gallbladder cancer. Br J Surg. 2020;107:289-300. https://doi.org/10.1002/bjs.11379
Guevara AO, Facundo H, Cardona H, Pinilla R, Escobar B, Oliveros R. Re-resection in incidental gallbladder cancer: lymph nodes retrieved in open vs laparoscopic approach. HPB. 2018;20(Suppl 1):S71. https://doi.org/10.1016/j.hpb.2018.02.297
Byun Y, Choi YJ, Kang JS, Han Y, Kim H, Kwon W, et al. Early outcomes of robotic extended cholecystectomy for the treatment of gallbladder cancer. J Hepatobiliary Pancreat Sci. 2020;27:324-30. https://doi.org/10.1002/jhbp.717
Matsumoto Y, Fujii H, Aoyama H, Yamamoto M, Sugahara K, Suda K. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg. 1992;163:239-45. https://doi.org/10.1016/0002-9610(92)90109-5
Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, et al. Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification. Journal of Hepato-biliary-pancreatic Surgery. 2007;14:358-65. https://doi.org/10.1007/s00534-006-1188-z
Mao W, Deng F, Wang D, Gao L, Gao L, Shi X. Treatment of advanced gallbladder cancer: A SEER-based study. Cancer Med. 2020;9:141-50. https://doi.org/10.1002/cam4.2679
Zhong H, Hao TT, Chen Y, Luo F. Unexpected gallbladder cancer during or after laparoscopic cholecystectomy: risk factors and experience of diagnosis and treatment of 22 cases. Am Surg. 2019;85:671-5. https://doi.org/10.1177/000313481908500633
Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273-81. https://doi.org/10.1056/NEJMoa0908721
Javle M, Churi C, Kang HC, Shroff R, Janku F, Surapaneni R, et al. HER2/neu-directed therapy for biliary tract cancer. J Hematol Oncol. 2015;8:58. https://doi.org/10.1186/s13045-015-0155-z
Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485-9. https://doi.org/10.1002/jso.21141
Kasumova GG, Tabatabaie O, Najarian RM, Callery M, Chau S, BullockA, et al. Surgical management of gallbladder cancer: simple versus extended cholecystectomy and the role of adjuvant therapy. Ann Surg. 2017;266:625-31. https://doi.org/10.1097/SLA.0000000000002385
Sachs TE, Akintorin O, Tseng J. How should gallbladder cancer be managed? Adv Surg. 2018;52:89-100. https://doi.org/10.1016/j.yasu.2018.04.003
Hickman L, Contreras C. Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies. Surg Clin North Am. 2019;99:337-55. https://doi.org/10.1016/j.suc.2018.12.008
Valle J. The Christie NHS Foundation Trust. Active symptom control alone or with mfolfox chemotherapy for locally advanced/metastatic biliary tract cancers (ABC06). NCT01926236. https://clinicaltrials.gov.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2022 Revista Colombiana de Cirugía
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Todos los textos incluidos en la Revista Colombiana de Cirugía están protegidos por derechos de autor. Las opiniones expresadas en los artículos firmados son las de los autores y no coinciden necesariamente con las de los directores o los editores de la Revista Colombiana de Cirugía. Las sugerencias diagnósticas o terapéuticas como elección de productos, dosificación y métodos de empleo corresponden a la experiencia y al criterio de los autores.
.jpg)
